Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 858735, 9 pages
http://dx.doi.org/10.1155/2010/858735
Research Article

Apocynin Improves Insulin Resistance through Suppressing Inflammation in High-Fat Diet-Induced Obese Mice

1Department of Endocrinology, Nanjing Drum Tower Hospital, Nanjing University School of Medicine, 321 Zhongshan Road, Nanjing 210008, China
2Department of Medical Genetics, Nanjing University School of Medicine, 22 Hankou Road, Nanjing 210093, China
3Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, 22 Hankou Road, Nanjing 210093, China

Received 27 October 2010; Accepted 17 December 2010

Academic Editor: Chiara De Luca

Copyright © 2010 Ran Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. T. James, N. Rigby, and R. Leach, “The obesity epidemic, metabolic syndrome and future prevention strategies,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 11, no. 1, pp. 3–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Tilg and A. R. Moschen, “Insulin resistance, inflammation, and non-alcoholic fatty liver disease,” Trends in Endocrinology and Metabolism, vol. 19, no. 10, pp. 371–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. Kang, G. Tsuyoshi, I. S. Han, T. Kawada, Y. M. Kim, and R. Yu, “Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet,” Obesity, vol. 18, no. 4, pp. 780–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Tilg and A. R. Moschen, “Inflammatory mechanisms in the regulation of insulin resistance,” Molecular Medicine, vol. 14, no. 3-4, pp. 222–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. A. Leclercq, G. C. Farrell, C. Sempoux, A. D. Peña, and Y. Horsmans, “Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice,” Journal of Hepatology, vol. 41, no. 6, pp. 926–934, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB,” Nature Medicine, vol. 11, no. 2, pp. 183–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Google Scholar · View at Scopus
  11. N. Kamei, K. Tobe, R. Suzuki et al., “Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance,” Journal of Biological Chemistry, vol. 281, no. 36, pp. 26602–26614, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Bastard, M. Maachi, J. T. van Nhieu et al., “Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2084–2089, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. N. Murthy, C. V. Desouza, N. W. Bost et al., “Effects of salsalate therapy on recovery from vascular injury in female zucker fatty rats,” Diabetes, vol. 59, no. 12, pp. 3240–3246, 2010. View at Publisher · View at Google Scholar
  14. E. Hopps, D. Noto, G. Caimi, and M. R. Averna, “A novel component of the metabolic syndrome: the oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 1, pp. 72–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Ho and T. M. Bray, “Antioxidants, NFκB activation, and diabetogenesis,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 205–213, 1999. View at Google Scholar · View at Scopus
  16. G. M. Campo, A. Avenoso, S. Campo et al., “The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-κB and caspase activation,” British Journal of Pharmacology, vol. 155, no. 6, pp. 945–956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Shapiro, M. Ashkenazi, N. Weizman, M. Shahmurov, H. Aeed, and R. Bruck, “Curcumin ameliorates acute thioacetamide-induced hepatotoxicity,” Journal of Gastroenterology and Hepatology, vol. 21, no. 2, pp. 358–366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Bruck, H. Aeed, Y. Avni et al., “Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats,” Journal of Hepatology, vol. 40, no. 1, pp. 86–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kamigaki, S. Sakaue, I. Tsujino et al., “Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 339, no. 2, pp. 624–632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Uchida, K. I. Ohba, T. Yoshioka, K. Irie, T. Muraki, and Y. Maru, “Cellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 4075–4083, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Sakurai, K. Kitadate, H. Nishioka et al., “Oligomerized grape seed polyphenols attenuate inflammatory changes due to antioxidative properties in coculture of adipocytes and macrophages,” Journal of Nutritional Biochemistry, vol. 21, no. 1, pp. 47–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Sakurai, H. Nishioka, H. Fujii et al., “Antioxidative effects of a new lychee fruit-derived polyphenol mixture, oligonol, converted into a low-molecular form in adipocytes,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 2, pp. 463–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Hougee, A. Hartog, A. Sanders et al., “Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice,” European Journal of Pharmacology, vol. 531, no. 1–3, pp. 264–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Viačková, M. Pekarová, T. Crhák et al., “Redox-sensitive regulation of macrophage-inducible nitric oxide synthase expression in vitro does not correlate with the failure of apocynin to prevent lung inflammation induced by endotoxin,” Immunobiology. In press. View at Publisher · View at Google Scholar
  25. O. Pechánová, L. Jendeková, and S. Vranková, “Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension,” Pharmacological Reports, vol. 61, no. 1, pp. 116–122, 2009. View at Google Scholar · View at Scopus
  26. A. Picchi, X. Gao, S. Belmadani et al., “Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome,” Circulation Research, vol. 99, no. 1, pp. 69–77, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Weber, W. Erl, A. Pietsch, M. Strobel, H. W. L. Ziegler-Heitbrock, and P. C. Weber, “Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals,” Arteriosclerosis and Thrombosis, vol. 14, no. 10, pp. 1665–1673, 1994. View at Google Scholar · View at Scopus
  28. A. A. Müller, S. A. Reiter, K. G. Heider, and H. Wagner, “Plant-derived acetophenones with antiasthmatic and anti-inflammatory properties: inhibitory effects on chemotaxis, right angle light scatter and actin polymerization of polymorphonuclear granulocytes,” Planta Medica, vol. 65, no. 7, pp. 590–594, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. R. B. R. Muijsers, I. van Ark, G. Folkerts et al., “Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice,” British Journal of Pharmacology, vol. 134, no. 2, pp. 434–440, 2001. View at Google Scholar · View at Scopus
  30. F. P. J. G. Lafeber, C. J. Beukelman, E. van den Worm et al., “Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis,” Rheumatology, vol. 38, no. 11, pp. 1088–1093, 1999. View at Google Scholar · View at Scopus
  31. S. S. Barbieri, V. Cavalca, S. Eligini et al., “Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms,” Free Radical Biology and Medicine, vol. 37, no. 2, pp. 156–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Winiarska, M. Grabowski, and M. K. Rogacki, “Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin,” Chemico-Biological Interactions. In press.
  33. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Thallas-Bonke, S. R. Thorpe, M. T. Coughlan et al., “Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway,” Diabetes, vol. 57, no. 2, pp. 460–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Edlund, A. Fasching, P. Liss, P. Hansell, and F. Palm, “The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 5, pp. 349–356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Olukman, C. E. Orhan, F. G. Celenk, and S. Ulker, “Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions,” Journal of Diabetes and Its Complications, vol. 24, no. 6, pp. 415–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Hayashi, P. A. R. Juliet, H. Kano-Hayashi et al., “NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction,” Diabetes, Obesity and Metabolism, vol. 7, no. 4, pp. 334–343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Yokota, S. Kinugawa, K. Hirabayashi et al., “Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 3, pp. H1069–H1077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Schenk, M. Saberi, and J. M. Olefsky, “Insulin sensitivity: modulation by nutrients and inflammation,” Journal of Clinical Investigation, vol. 118, no. 9, pp. 2992–3002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. P. Kopp, C. W. Kopp, A. Festa et al., “Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 6, pp. 1042–1047, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. V. Considine, M. K. Sinha, M. L. Heiman et al., “Serum immunoreactive-leptin concentrations in normal-weight and obese humans,” New England Journal of Medicine, vol. 334, no. 5, pp. 292–295, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Antuna-Puente, B. Feve, S. Fellahi, and J. P. Bastard, “Adipokines: the missing link between insulin resistance and obesity,” Diabetes and Metabolism, vol. 34, no. 1, pp. 2–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Luo, J. Liu, B. H. Chung et al., “Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis,” Diabetes, vol. 59, no. 4, pp. 791–799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Akira, T. Taga, and T. Kishimoto, “Interleukin-6 in biology and medicine,” Advances in Immunology, vol. 54, pp. 1–78, 1993. View at Google Scholar · View at Scopus
  47. B. A. Hart and J. M. Simons, “Metabolic activation of phenols by stimulated neutrophils: a concept for a selective type of anti-inflammatory drug,” Biotechnology Therapeutics, vol. 3, no. 3-4, pp. 119–135, 1992. View at Google Scholar · View at Scopus
  48. A. Pandey, K. Kour, S. Bani et al., “Amelioration of adjuvant induced arthritis by apocynin,” Phytotherapy Research, vol. 23, no. 10, pp. 1462–1468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. K. Roy, “Transcription factors and aging,” Molecular Medicine, vol. 3, no. 8, pp. 496–504, 1997. View at Google Scholar · View at Scopus
  50. R. Schreck, P. Rieber, and P. A. Baeuerle, “Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1,” EMBO Journal, vol. 10, no. 8, pp. 2247–2258, 1991. View at Google Scholar · View at Scopus
  51. R. A. Clark and A. J. Valente, “Nuclear factor kappa B activation by NADPH oxidases,” Mechanisms of Ageing and Development, vol. 125, no. 10-11, pp. 799–810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. S. S. Brar, T. P. Kennedy, A. B. Sturrock et al., “NADPH oxidase promotes NF-κB activation and proliferation in human airway smooth muscle,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 282, no. 4, pp. L782–L795, 2002. View at Google Scholar · View at Scopus